Inventor · disambiguated record
Stipan Jonjic
Also filed as: JONJIC STIPAN
6 granted patents·8 pending applications·5 citations·filing 2012–2024
72Inventor score
Files withYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD9HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH1JONJIC STIPAN1NECTIN THERAPEUTICS LTD1UNIV FREIBURG ALBERT LUDWIGS1
Top patents by PatentIndex Score
14 records- 0175US2024018257A1Antibodies specific to human poliovirus receptor (pvr)YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2023·Application pending·0 cites
- 0274US10716864B2Anti-NKP46 antibodies, toxin conjugates, and therapeutic use of sameYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2018·Granted Jul 21, 2020·2 cites·37 claims
- 0373US10537621B2Vaccine comprising beta-herpesvirusUNIV OF RIJEKA FACULTY OF MEDICINE·Filed 2016·Granted Jan 21, 2020·2 cites·15 claims
- 0468US10946095B2Antibodies specific to human T-cell immunoglobulin and ITIM domain (TIGIT)YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2016·Granted Mar 16, 2021·1 cites·13 claims
- 0567US2024376202A1Antibodies specific to human nectin4YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2024·Application pending·0 cites
- 0664US2021115150A1Antibodies specific to human poliovirus receptor (pvr)YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2020·Application pending·0 cites
- 0762US12121579B2Antibodies specific to human t-cell immunoglobulin and ITIM domain (TIGIT)YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2021·Granted Oct 22, 2024·0 cites·16 claims
- 0860US2025092421A1A murine cytomegalovirus vaccine vector for administration in a non-mouse subjectHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH·Filed 2023·Application pending·0 cites
- 0957US12077583B2Antibodies specific to human NECTIN4YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2019·Granted Sep 3, 2024·0 cites·13 claims
- 1057US10906987B2Antibodies specific to human poliovirus receptor (PVR)YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2017·Granted Feb 2, 2021·0 cites·11 claims
- 1148US2025270295A1Application of hcmv gp34- and gp68-specific antibodies and fragments thereof for prevention, therapy and diagnostics of hcmv diseaseUNIV FREIBURG ALBERT LUDWIGS·Filed 2022·Application pending·0 cites
- 1247US2023183342A1Antibodies to nkp46 and constructs thereof for treatment of cancers and infectionsYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2021·Application pending·0 cites
- 1345US2013156808A1Vaccine comprising beta-herpesvirusJONJIC STIPAN·Filed 2012·Application pending·0 cites
- 1442US2024270840A1Antibodies against cd112r and uses thereofNECTIN THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stipan Jonjic files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →